Brief: Greenlight Biosciences Holdings, PBC (GRNA) Enters Into Multitarget Licensing Agreement With Serum Institute Of India To Develop And Commercialize Messenger RNA Products For Emerging Markets Globally

Greenlight Biosciences Holdings PBC

14/03/2022 14:02

March 14 (Reuters) - Greenlight Biosciences Holdings PBC
 GRNA.O :
    * GREENLIGHT BIOSCIENCES HOLDINGS, PBC (GRNA) ENTERS INTO
MULTITARGET LICENSING AGREEMENT WITH SERUM INSTITUTE OF INDIA TO
DEVELOP AND COMMERCIALIZE MESSENGER RNA PRODUCTS FOR EMERGING
MARKETS GLOBALLY
    * GREENLIGHT BIOSCIENCES - WILL MAKE A TECHNOLOGY TRANSFER
OF ITS
SCALABLE AND COST-EFFECTIVE MANUFACTURING PROCESS TO SERUM
INSTITUTE OF INDIA
    * GREENLIGHT BIOSCIENCES HOLDINGS PBC - WILL RECEIVE
PAYMENTS
UPFRONT, AND FOR NEAR-TERM MILESTONES AND IN A PROFIT-SHARING
AGREEMENT
    * GREENLIGHT BIOSCIENCES - SII WILL PAY ALL DEVELOPMENT,
MANUFACTURING, AND COMMERCIALIZATION COSTS FOR EACH PRODUCT IN
EMERGING MARKETS
    * GREENLIGHT BIOSCIENCES - WILL RECEIVE PAYMENTS UPFRONT,
AND FOR
NEAR-TERM MILESTONES AND IN A PROFIT-SHARING AGREEMENT
    * GREENLIGHT - RETAINS RIGHT TO DEVELOP,
MANUFACTURE,COMMERCIALIZE
PRODUCTS IN NORTH AMERICA, EUROPE, AUSTRALIA, NEW ZEALAND,
CHINA, JAPAN, AND SOUTH KOREA

Source text for Eikon:  ID:nGNX7yFRlZ 
Further company coverage:  GRNA.O 

 ((Reuters.Briefs@thomsonreuters.com;))